Patent · US Active

5-bromo-indirubins

US11306072B2 · kind B2 · utility

1Cited by

4References

3Claims

0Family size

Assignees

City of Hope · US
National and Kapodistrian University of Athens · GR

Inventors

Richard Jove · Pasadena, US
Sangkil Nam · Duarte, US
David Horne · Altadena, US
Jun Xie · Duarte, US
Alexios Leandros Skaltsounis · Athens, GR
Marina Kritsanida · Athens, GR
Nicolas Gaboriaud-Kolar · Athens, GR

Key dates

Filing date	Feb 13, 2020
Grant date	Apr 19, 2022
Priority date	—
Expiry date	Feb 13, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein inter alia are compositions and methods for treating cancer using 5-Br-indirubin derivatives.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.